IL28 Receptor alpha (IFNLR1) Human shRNA Plasmid Kit (Locus ID 163702)
CAT#: TR303938
IFNLR1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 6,790.00
货期*
2周
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
IFNLR1 mouse monoclonal antibody,clone OTI8G1
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | IL28 Receptor alpha (IFNLR1) Human shRNA Plasmid Kit (Locus ID 163702) |
Locus ID | 163702 |
UniProt ID | Q8IU57 |
Synonyms | CRF2/12; IFNLR; IL-28R1; IL28RA; LICR2 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | IFNLR1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 163702). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | BC006120, BC024651, NM_170743, NM_173064, NM_173065, NM_173065.1, NM_173065.2, NM_173064.1, NM_173064.2, NM_170743.1, NM_170743.2, NM_170743.3, BC101407, BC101408, BC101975, BC139722, BC140872, NM_173064.3, NM_170743.4, NM_173065.3 |
Summary | The protein encoded by this gene belongs to the class II cytokine receptor family. This protein forms a receptor complex with interleukine 10 receptor, beta (IL10RB). The receptor complex has been shown to interact with three closely related cytokines, including interleukin 28A (IL28A), interleukin 28B (IL28B), and interleukin 29 (IL29). The expression of all three cytokines can be induced by viral infection. The cells overexpressing this protein have been found to have enhanced responses to IL28A and IL29, but decreased response to IL28B. Three alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
IL28RA inhibits human epidermal keratinocyte proliferation by inhibiting cell cycle progression.
,null,
Molecular biology reports
,PubMed ID 30632069
[IFNLR1]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...